PT Jayamas Medica Industri Tbk (IDX:OMED)
Indonesia · Delayed Price · Currency is IDR 234.00
+6.00 (2.63%)
Aug 12, 2026, 4:13 PM WIB
IDX:OMED Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,157,851 | 5,567,260 | 4,870,593 | 5,790,594 | 5,736,476 | - | |
Market Cap Growth | 24.41% | 14.30% | -15.89% | 0.94% | - | - |
Enterprise Value | 5,038,279 | 4,526,158 | 3,842,403 | 4,959,593 | 5,138,821 | - |
Last Close Price | 228.00 | 201.92 | 172.77 | 202.45 | 197.26 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.25 | 15.17 | 15.14 | 22.33 | 20.07 | - |
Forward PE | 15.15 | 14.48 | 16.36 | 21.84 | - | - |
PS Ratio | 2.67 | 2.70 | 2.58 | 3.33 | 3.30 | - |
PB Ratio | 2.15 | 2.02 | 1.95 | 2.58 | 2.77 | - |
P/TBV Ratio | 2.18 | 2.05 | 1.98 | 2.61 | 2.81 | - |
P/FCF Ratio | 24.36 | 19.40 | 18.72 | - | 326.88 | - |
P/OCF Ratio | 16.47 | 14.09 | 13.44 | 43.10 | 61.94 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.19 | 2.19 | 2.04 | 2.86 | 2.96 | - |
EV/EBITDA Ratio | 9.38 | 10.19 | 9.89 | 14.82 | 13.09 | - |
EV/EBIT Ratio | 10.99 | 11.61 | 11.12 | 16.52 | 13.81 | - |
EV/FCF Ratio | 19.93 | 15.77 | 14.77 | - | 292.83 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.08 | 0.07 | 0.08 | 0.10 | 0.15 |
Debt / EBITDA Ratio | 0.49 | 0.47 | 0.46 | 0.53 | 0.48 | 0.24 |
Debt / FCF Ratio | 1.04 | 0.75 | 0.71 | - | 11.38 | 0.44 |
Net Debt / Equity Ratio | -0.40 | -0.41 | -0.45 | -0.44 | -0.55 | -0.52 |
Net Debt / EBITDA Ratio | -2.24 | -2.54 | -2.90 | -2.97 | -2.88 | -0.87 |
Net Debt / FCF Ratio | -4.57 | -3.93 | -4.34 | 45.16 | -64.44 | -1.54 |
Asset Turnover | 0.74 | 0.69 | 0.70 | 0.68 | 0.82 | 1.42 |
Inventory Turnover | 2.10 | 1.83 | 1.92 | 1.97 | 2.34 | 3.76 |
Quick Ratio | 5.73 | 6.92 | 5.36 | 10.26 | 6.57 | 3.75 |
Current Ratio | 8.29 | 10.36 | 7.66 | 15.04 | 9.15 | 5.46 |
Return on Equity (ROE) | 16.10% | 14.06% | 13.67% | 12.10% | 17.53% | 51.95% |
Return on Assets (ROA) | 9.17% | 8.09% | 7.98% | 7.37% | 10.99% | 29.15% |
Return on Invested Capital (ROIC) | 21.29% | 21.12% | 21.70% | 21.99% | 37.92% | 113.16% |
Return on Capital Employed (ROCE) | 14.80% | 13.20% | 13.70% | 12.30% | 16.40% | 50.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.03% | 6.59% | 6.60% | 4.48% | 4.98% | - |
FCF Yield | 4.11% | 5.15% | 5.34% | -0.38% | 0.31% | - |
Dividend Yield | 1.77% | 2.02% | 2.07% | 2.99% | - | - |
Payout Ratio | 22.32% | 26.31% | 24.23% | 33.07% | 87.48% | 45.32% |
Buyback Yield / Dilution | 0.09% | 0.07% | - | - | - | 1.44% |
Total Shareholder Return | 1.87% | 2.09% | 2.07% | 2.99% | - | 1.44% |